• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Exclusives
    • Nutraceuticals
    • Markets
    • Health
    • Jobs
    • Events
    • Buyers' Guide
    • Showcases
    • More
  • Magazine
  • News
  • Exclusives
  • Nutraceuticals
  • Markets
  • Health
  • Jobs
  • Events
  • Buyers' Guide
  • Showcases
  • Current & Past Issues
    Features
    Columns
    Editorials
    Digital Edition
    Subscribe Now
    Advertise Now
    eNewsletter
    Editorial Guidelines
    Top Features
    Nutraceuticals for Men: Muscle Health and Performance Nutrition

    Aging in Place: Healthy Lifestyles Supplement Science-Based Solutions

    Getting an Edge in Esports: Meeting the Health Needs of Competitive Gamers

    Beyond CBD: Cannabis Compounds Warrant Recognition and More Research

    Leveling Out the Energy Segment for Mainstream, and Rethinking Caffeine
    Breaking News
    Certifications, Approvals and Patents
    Exclusives
    Industry & Market News
    People
    Products
    Regulatory
    Research
    Supplier News
    Supplier Insights
    Live From Shows
    Top News
    GOED Creates Infographic Highlighting Omega-3 Health Claims Approved in Europe

    Kyowa Hakko Appoints Dr. Colin Hill to Immuse Scientific Advisory Board

    Expert Consensus Statement: Diet is Best Primary Intervention to Achieve Diabetes Remission

    Choline Alone May Improve Maternal DHA Status During Pregnancy

    Cranberry Consumption Linked to Memory and Neurological Function Improvements
    Exclusives
    Blogs & Guest Articles
    Health E-Insights
    Area Code 420
    eBook
    Antioxidants
    Dairy-Based Ingredients
    Enzymes
    Fatty Acids
    Fiber & Carbohydrates
    Green Foods
    Herbs & Botanicals
    Marine Nutraceuticals
    Minerals
    Omega 3s
    Probiotics & Prebiotics
    Proteins, Peptides, Amino Acids
    Sweeteners
    Vitamins

    GOED Creates Infographic Highlighting Omega-3 Health Claims Approved in Europe

    Kyowa Hakko Appoints Dr. Colin Hill to Immuse Scientific Advisory Board

    Choline Alone May Improve Maternal DHA Status During Pregnancy

    Cranberry Consumption Linked to Memory and Neurological Function Improvements

    Bilberon Bilberry Extract Receives U.S. Patent For Eye Strain, Neck/Shoulder Pain
    Consumer Trends
    Contract Manufacturing
    Cosmeceuticals / Nutricosmetics
    Delivery & Dosage Technologies
    Dietary Supplements
    Flavors & Colors
    Functional Foods & Beverages
    Healthcare Trends
    Medical Nutrition
    Mergers & Acquisitions
    Natural/Organic
    Nutrition Bars
    Packaging
    Pet Nutraceuticals
    Quality & Safety
    Regulations
    Research
    Testing
    World Markets

    FDA Issues Draft Guidance on NDI Enforcement Discretion

    GOED Creates Infographic Highlighting Omega-3 Health Claims Approved in Europe

    Kyowa Hakko Appoints Dr. Colin Hill to Immuse Scientific Advisory Board

    Expert Consensus Statement: Diet is Best Primary Intervention to Achieve Diabetes Remission

    Choline Alone May Improve Maternal DHA Status During Pregnancy
    Bone & Joint Health
    Cancer Risk
    Cardiovascular Health
    Cognitive Function
    Diabetes & Blood Sugar Management
    Digestive Health
    Energy
    Eye Health
    Healthy Aging
    Immune Function
    Infant & Children's Health
    Inflammation
    Men's Health
    Mood Health & Sleep
    Oral Health
    Sexual & Reproductive Health
    Skin Health
    Sports Nutrition
    Weight Management/Weight Loss
    Women's Health

    Kyowa Hakko Appoints Dr. Colin Hill to Immuse Scientific Advisory Board

    Expert Consensus Statement: Diet is Best Primary Intervention to Achieve Diabetes Remission

    Choline Alone May Improve Maternal DHA Status During Pregnancy

    Cranberry Consumption Linked to Memory and Neurological Function Improvements

    Bilberon Bilberry Extract Receives U.S. Patent For Eye Strain, Neck/Shoulder Pain
    Industry Events
    Live From Show Events
    Webinars
    All Companies
    Categories
    Trade Associations
    Company Capabilities
    International Buyers Guide Companies
    Nutrition21, LLC

    Atlantia Clinical Trials

    ESHA Research

    KLK OLEO

    Applied Food Sciences, Inc.
    Companies
    Product Releases
    News Releases
    Literature / Brochures
    White Papers
    Jobs
    VIdeos
    Services
    Add New Company
    International Buyers Guide Companies
    Nutrition21, LLC

    Atlantia Clinical Trials

    ESHA Research

    KLK OLEO

    Applied Food Sciences, Inc.
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Digital Edition
      • eNewsletter Archive
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
    • Breaking News
    • Buyers' Guide
      • All Companies
      • Categories
      • Trade Associations
      • Company Capabilities
    • Nutraceuticals
      • Antioxidants
      • Dairy-Based Ingredients
      • Enzymes
      • Fatty Acids
      • Fiber & Carbohydrates
      • Green Foods
      • Herbs & Botanicals
      • Marine Nutraceuticals
      • Minerals
      • Omega 3s
      • Probiotics & Prebiotics
      • Proteins, Peptides, Amino Acids
      • Sweeteners
      • Vitamins
    • Markets
      • Consumer Trends
      • Contract Manufacturing
      • Cosmeceuticals / Nutricosmetics
      • Delivery & Dosage Technologies
      • Dietary Supplements
      • Flavors & Colors
      • Functional Foods & Beverages
      • Healthcare Trends
      • Medical Nutrition
      • Mergers & Acquisitions
      • Natural/Organic
      • Nutrition Bars
      • Packaging
      • Pet Nutraceuticals
      • Quality & Safety
      • Regulations
      • Research
      • Testing
      • World Markets
    • Health
      • Bone & Joint Health
      • Cancer Risk
      • Cardiovascular Health
      • Cognitive Function
      • Diabetes & Blood Sugar Management
      • Digestive Health
      • Energy
      • Eye Health
      • Healthy Aging
      • Immune Function
      • Infant & Children's Health
      • Inflammation
      • Men's Health
      • Mood Health & Sleep
      • Oral Health
      • Sexual & Reproductive Health
      • Skin Health
      • Sports Nutrition
      • Weight Management/Weight Loss
      • Women's Health
    • Online Exclusives
    • Webinars
    • Slideshows
    • Blogs & Guest Articles
    • Health E-Insights
    • Videos
    • Podcasts
    • Infographics
    • eBook
    • Whitepapers
    • Research
      • TrendSense
      • Monograph Center
      • White Papers
      • Research News
    • Jobs
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Supplier Showcases
      • Companies
      • Product Releases
      • News Releases
      • Literature / Brochures
      • White Papers
      • Jobs
      • VIdeos
      • Services
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Columns

    The Importance of Significant Scientific Agreement for Medical Foods

    Industry must be prepared to meet and exceed regulatory and scientific standards.

    The Importance of Significant Scientific Agreement for Medical Foods
    Windrose Partners estimates the U.S. medical foods market is worth about $3 billion.
    Related CONTENT
    • Autophagy (the Body’s Garbage Disposal) Key to Cellular Renewal
    • The Nuts and Bolts of FDA’s 2023 Budget Request
    • Lanfam LLC Launches Medical Food for Pain Relief
    • The Value of Clinical Evidence Supporting Nutraceuticals
    • NEM Eggshell Membrane Receives Novel Food Approval from India’s FSSAI
    Greg Stephens, Sheila Campbell, PhD, RD, & Sandy Bigelow, PhD11.02.15
    Every day there is news about advances in nutrition science. We are learning more about the role of nutrition, dietary components and bioactive compounds in health and disease processes. People with diseases and conditions that initially could only be addressed through drug therapies may now benefit from dietary management of those conditions as well. Of course, FDA has made it clear that dietary supplements are intended for use by healthy individuals. However, there is an avenue for nutritional products that have a role in the dietary management of a disease or its metabolic processes: the regulatory category of “medical foods.”

    Over the last two years the volume of our consulting activities at Windrose Partners has seen a rather dramatic increase in projects related to the medical food market. In this month’s Business Insights column I have invited two Windrose Associates, Sheila Campbell, PhD, RD, and Sandy Bigelow, PhD, to assist in addressing a key, and sometimes confusing, aspect of medical food regulations: the significant scientific agreement dossier supporting claims.

    A Regulatory Primer
    The concept of specially formulated foods for seriously ill patients is certainly not new. These special foods were developed as early as the 1940s and FDA proposed its first definition for Foods for Special Dietary Use (FSDU) in 1941. Prior to 1941 the agency regulated these types of products as drugs. The 1988 Orphan Drug Amendments provided the first statutory definition of the term “medical food” as follows: “A food which is formulated to be consumed or administered enterally under the supervision of a physician and which is intended for the specific dietary management of a disease or condition for which distinctive nutritional requirements, based on recognized scientific principles, are established by medical evaluation,” (21 U.S.C. 360ee(b)(3).

    The size of the medical foods market remains difficult to estimate. Windrose Partners estimates the U.S. market at $3 billion. The majority of sales are to healthcare institutions—hospitals, nursing homes and home care agencies. Increasingly, medical foods are being marketed direct to health practitioners and even distributed through retail channels, still requiring they be used under medical supervision. The market is projected to continue low double-digit growth over the next few years, driven primarily by the aging population and advances in nutrition science.

    By definition, when used to provide dietary management, medical foods must provide “medically determined nutrient requirements, the dietary management of which cannot be achieved by the modification of the normal diet alone,” (21 CFR 101.9(j)(8)). Unlike drugs, medical foods do not require years of costly product safety and efficacy testing and FDA premarket approval. Consequently, medical foods are gaining importance as cost-effective components of disease management. Bear in mind though, approval of claims for medical foods requires that a credible case is made that the medical food has scientific rigor and consistency with regulatory requirements through medical evaluation.

    The 1990 Nutritional Labeling and Education Act (NLEA) required FDA to issue regulations authorizing the use of a health claim only when evidence demonstrated that “significant scientific agreement” (SSA) was met. Significant scientific agreement is the quality and quantity of evidence FDA defines as sufficient to demonstrate agreement by qualified experts regarding the claim. Health claims are intended for labeling of foods and supplements consumed by healthy people. Medical foods are intended to address management of diseases through consumption by patients under the care of a healthcare practitioner.

    Substantiating claims requires development of a scientific dossier demonstrating a specific disease or medical condition has distinct nutritional needs that cannot be otherwise met through modification of the diet alone. It is insufficient to state the product works nutritionally if the scientific literature does not show the medical food components are necessary. However, neither the NLEA nor FDA specified the content or appearance of an acceptable SSA.

    In 1999, FDA issued “Guidance for Industry: Significant Scientific Agreement in the Review of Health Claims for Conventional Foods and Dietary Supplements.” This document clarified the agency’s interpretation of SSA but still did not clearly define the meaning of the term. In 2009, FDA issued guidance outlining its approach to evaluating scientific evidence for health claims. Petitions for health claims undergo both a scientific and a regulatory review. 

    SSA Dossier Contents to Support Health Claims
    The most important scientific document a petitioner can have is an SSA dossier. Ideally, the person developing the SSA document has academic and clinical expertise. The ideal person to develop this document is a person knowledgeable and experienced in searching, reading, dissecting and interpreting the literature. Select someone who has a researcher-level understanding of the following issues and ability to apply them in a clinical context:
    • Research question development
    • Study design
    • Appropriate study population and sample size
    • Data collection methods
    • Statistical test selection
    • Data analysis
    • Interpreting findings
    The SSA consists of a thorough, comprehensive and objective review of the medical and scientific literature defining the substance/disease relationship, and answers these critical questions:

    • Have the studies specified and measured the substance that is the subject of the claim?
    • Have the studies appropriately specified and measured the specific disease or health-related condition that is the subject of the claim?
    • What is the type of study and is it appropriate to answer the question (e.g., intervention studies, prospective and retrospective, observational studies, research synthesis studies, animal and in vitro studies)?
    • Were appropriate outcomes and surrogate endpoints identified and used?
    • Were the appropriate study population and sample size identified and used?
    • Were study methods appropriate?
    • Were the data appropriately collected and analyzed?
    • Was the study site and length appropriate to collect meaningful data?
    • Were the study results appropriate to the U.S. population?
    The SSA defined two elements: 1) consensus requirement and 2) evidence requirements (as implied, if the questions are answered properly). Even though SSA is not a statutory mandate for determining the adequacy of the evidence for claims used in medical food labeling, the evidence requirements of SSA elaborated here can help to define a framework for assembling the scientific and clinical evidence for such labeling. 

    Clearly, SSA denotes a form of consensus in the community of scientists to agree that a claim is supported. FDA has often used conclusions of the Institute of Medicine, Life Sciences Research Office and the American Society of Nutritional Sciences (both of the Federation of American Societies for Experimental Biology, FASEB), and the American Academy of Pediatrics as a basis to form SSA. SSA does not require consensus to the degree of unanimity or even a putative agreement among scientists, whereas a consensus of the majority of scientists may be debatable. 

    For medical foods, especially for conditions in which few patients are afflicted (e.g., inborn errors of metabolism), reaching significant scientific agreement is difficult at best because so few scientists/clinicians are knowledgeable of the condition(s) studied. Thus, the evidence requirements for SSA may be useful for assembling the information required to substantiate medical food claims. Medical foods are developed through medical evaluation based on recognized scientific principles (21 U.S.C. 360ee(b)(3), 21 CFR 101.9(j)(8)). Many of the evidence requirements, in the form of questions, elaborated above incorporate recognized scientific principles. 

    The benefits of medical foods, substantiated by sound clinical research, are increasingly understood and supported by physicians and other health practitioners. As the science continues to drive innovation the market will grow. FDA has defined this regulatory category offering health practitioners the products and educational tools necessary to address the dietary management of some serious health conditions. It is up to the industry to meet and exceed the regulatory and scientific standards these patient populations require and deserve. 


    Gregory Stephens
    Greg Stephens is president of Windrose Partners, a company serving clients in the the dietary supplement, functional food and natural product industries. Formerly vice president of strategic consulting with The Natural Marketing Institute (NMI) and vice president of sales and marketing for Nurture, Inc (OatVantage), he has 25 years of specialized expertise in the nutritional and pharmaceutical industries. His prior experience includes a progressive series of senior management positions with Abbott Nutrition (Ross Products Division of Abbott Laboratories), including development of global nutrition strategies for disease-specific growth platforms and business development for Abbott’s medical foods portfolio. He can be reached at 267-432-2696; E-mail: gregstephens@windrosepartners.com.

    Sheila Campbell
    Sheila Campbell, PhD, RD, has practiced in the field of clinical nutrition for more than 30 years, including 17 years with Ross Products Division of Abbott Laboratories. She has authored more than 70 publications on scientific, clinical and medical topics and has presented 60 domestic and international lectures on health-related topics. She can be reached at smcampbellphdrd@gmail.com.

    Sandy Bigelow
    Sandy Bigelow, PhD, principal, Vanguard Global Associates LLC, is a research and development professional with more than 20 years of experience in leading global technology responsibilities in the food, nutrition and medical device industries. He can be reached at sandy@vanguardglobalassociates.com.
    Related Searches
    • Healthcare
    • Medical Foods
    • labeling
    • Medical Food
    Related Knowledge Center
    • Testing
    • Regulations
    • Healthcare Trends
    Suggested For You
    Autophagy (the Body’s Garbage Disposal) Key to Cellular Renewal Autophagy (the Body’s Garbage Disposal) Key to Cellular Renewal
    The Nuts and Bolts of FDA’s 2023 Budget Request The Nuts and Bolts of FDA’s 2023 Budget Request
    Lanfam LLC Launches Medical Food for Pain Relief Lanfam LLC Launches Medical Food for Pain Relief
    The Value of Clinical Evidence Supporting Nutraceuticals The Value of Clinical Evidence Supporting Nutraceuticals
    NEM Eggshell Membrane Receives Novel Food Approval from India’s FSSAI NEM Eggshell Membrane Receives Novel Food Approval from India’s FSSAI
    Astaxanthin: The Rising Star for Developing New Immune Products Astaxanthin: The Rising Star for Developing New Immune Products
    Understanding Exclusion (Preclusion) and a Proposed Solution Understanding Exclusion (Preclusion) and a Proposed Solution
    Claims Spell Success in Today’s Nutritional Products Market Claims Spell Success in Today’s Nutritional Products Market
    Disrupting the Immune Health Category in 2021 & Beyond Disrupting the Immune Health Category in 2021 & Beyond
    Understanding FTC Standards for Claims Substantiation Understanding FTC Standards for Claims Substantiation
    Transforming Health with Nature’s Sunshine Transforming Health with Nature’s Sunshine
    Unfolding the Interrelationship Between GI Health & Immunity Unfolding the Interrelationship Between GI Health & Immunity
    TREHA Trehalose Available As ‘Natural Flavor’ TREHA Trehalose Available As ‘Natural Flavor’
    Weighty Matters: Implications for Repeal of the Affordable Care Act Weighty Matters: Implications for Repeal of the Affordable Care Act
    Cyber-Security Questions for Nutraceutical Company Executives Cyber-Security Questions for Nutraceutical Company Executives

    Related Content

    • Dietary Supplements | Healthy Aging | Herbs & Botanicals | Medical Nutrition
      Autophagy (the Body’s Garbage Disposal) Key to Cellular Renewal

      Autophagy (the Body’s Garbage Disposal) Key to Cellular Renewal

      Researchers have been studying autophagy and its role in the development of chronic disease and the physical changes associated with aging.
      By Gregory Stephens, Windrose Partners, and Sheila Campbell, PhD, RD 04.14.22

    • Dietary Supplements | Quality & Safety | Regulations
      The Nuts and Bolts of FDA’s 2023 Budget Request

      The Nuts and Bolts of FDA’s 2023 Budget Request

      The U.S. Food and Drug Administration is prioritizing multiple ways to regulate the dietary supplements industry in its request for an $8.4 billion budget.
      By Mike Montemarano, Associate Editor 04.12.22

    • Breaking News | Herbs & Botanicals | Inflammation | Medical Nutrition | Products | Proteins, Peptides, Amino Acids
      Lanfam LLC Launches Medical Food for Pain Relief

      Lanfam LLC Launches Medical Food for Pain Relief

      Proleeva is formulated to address amino acid deficiencies seen in inflammatory disorders and chronic pain.
      03.21.22


    • Dietary Supplements | Healthcare Trends | Quality & Safety | Research
      The Value of Clinical Evidence Supporting Nutraceuticals

      The Value of Clinical Evidence Supporting Nutraceuticals

      Consumers look for safety and efficacy, so investment in research can offer a favorable return if outcomes and quality of life are shown to improve.
      By Greg Stephens, Windrose Partners, and David Wilson, MA 01.26.22

    • Bone & Joint Health | Breaking News | Certifications, Approvals & Patents | Contract Manufacturing | Dietary Supplements | Healthy Aging | Natural/Organic | Proteins, Peptides, Amino Acids | Quality & Safety | Research | World Markets
      NEM Eggshell Membrane Receives Novel Food Approval from India’s FSSAI

      NEM Eggshell Membrane Receives Novel Food Approval from India’s FSSAI

      Stratum Nutrition’s ingredient was the subject of a multi-year review by the agency which included analysis of 16 clinical studies.
      12.01.21

      Trending
      • Vitamin D3, Omega-3s, Exercise May Cumulatively Reduce Cancer Risk In Older Adults | Nutraceuticals World
      • Leaven Essential To Launch Branded Botanical Extracts To Global Markets | Nutraceuticals World
      • Vitamin D3, Omega-3s, Exercise May Cumulatively Reduce Cancer Risk in Older Adults
      • Oregon Files Lawsuit Against GNC | Nutraceuticals World
      • Vitamin K2 Status May Impact Blood Pressure And Pulse Wave Velocity | Nutraceuticals World
      Breaking News
      • GOED Creates Infographic Highlighting Omega-3 Health Claims Approved in Europe
      • Kyowa Hakko Appoints Dr. Colin Hill to Immuse Scientific Advisory Board
      • Expert Consensus Statement: Diet is Best Primary Intervention to Achieve Diabetes Remission
      • Choline Alone May Improve Maternal DHA Status During Pregnancy
      • Cranberry Consumption Linked to Memory and Neurological Function Improvements
      View Breaking News >
      CURRENT ISSUE

      May 2022

      • Aging in Place: Lifestyle Supplements Science-Based Solutions
      • Getting an Edge in Esports: Meeting Health & Nutrition Needs
      • Nutraceuticals for Men: Muscle Health and Performance Nutrition

      Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
      You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

      • About Us
      • Privacy Policy
      • Terms And Conditions
      • Contact Us

      follow us

      Subscribe
      Nutraceuticals World

      Latest Breaking News From Nutraceuticals World

      GOED Creates Infographic Highlighting Omega-3 Health Claims Approved in Europe
      Kyowa Hakko Appoints Dr. Colin Hill to Immuse Scientific Advisory Board
      Expert Consensus Statement: Diet is Best Primary Intervention to Achieve Diabetes Remission
      Coatings World

      Latest Breaking News From Coatings World

      What Are You Reading?
      Teknos Receives EcoVadis Gold Medal for Sustainability Performance
      AkzoNobel and Partners Team Up to Hack Carbon Reduction Challenges
      Medical Product Outsourcing

      Latest Breaking News From Medical Product Outsourcing

      MPO's Most-Read Stories This Week—May 21
      Iterative Scopes Expands its Senior Leadership Team
      Viz.ai Raises $100 Million in Series D Funding
      Contract Pharma

      Latest Breaking News From Contract Pharma

      Piramal Pharma Solutions New API Plant in Canada Now Online
      MG America Appoints Claudio Radossi as President
      Catalent Invests $175M to Expand Mfg. Capabilities at Winchester, KY
      Beauty Packaging

      Latest Breaking News From Beauty Packaging

      Authentic Beauty Concept Launches Second-Generation ‘Refill Bar’
      HASK Beauty Enters Exclusive Partnership with Amazon
      Garance Doré Launches Made in France Skincare Line
      Happi

      Latest Breaking News From Happi

      P&G Closes HQ Due To Security Threat, Launches New Hair Care Line
      SPF Setting Spray, Lip Contour and Knotless Braids Are Hot Trends: Spate
      Nutrafol Launches Collagen Infusion
      Ink World

      Latest Breaking News From Ink World

      Weekly Recap: Zeller+Gmelin, Sun Chemical and Kornit Top This Week’s News
      Nazdar Celebrates 100 Years with a New Look
      hubergroup Chemicals Exhibits at Paint India for First Time
      Label & Narrow Web

      Latest Breaking News From Label & Narrow Web

      Brook + Whittle's new acquisition, SunDance goes to HP and more
      Specialty announces move to new facility
      Mark Andy hosts dealer's open house in Warsaw
      Nonwovens Industry

      Latest Breaking News From Nonwovens Industry

      Weekly Recap: Kimberly-Clark to Expand Diaper, Wipes Production in Brazil; The Honest Company to Sell Diapers, Wipes at Walmart & More
      3M to Expand in Nebraska
      Nicely Offers Nonwoven Slitters, Winders
      Orthopedic Design & Technology

      Latest Breaking News From Orthopedic Design & Technology

      ODT's Most Read Stories This Week—May 21
      FDA Clears Anika Therapeutics' X-Twist Knotless Fixation System
      Paragon 28 Rolls Out TenoTac 2.0 Hammertoe and Soft Tissue Repair
      Printed Electronics Now

      Latest Breaking News From Printed Electronics Now

      Weekly Recap: Graphene Flagship, Japan Display and LG Display Top This Week’s Stories
      Evonik Launches New Processing Aids for PV Wafer Cutting
      NREL Creates Highest Efficiency 1-Sun Solar Cell

      Copyright © 2022 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

      AD BLOCKER DETECTED

      Our website is made possible by displaying online advertisements to our visitors.
      Please consider supporting us by disabling your ad blocker.


      FREE SUBSCRIPTION Already a subscriber? Login